Fitzgerald Kevin Joseph insider trades
Fitzgerald Kevin Joseph has filed 23 Form 4s with the SEC that we hold, for Alnylam Pharmaceuticals, INC. (ALNY) (CSO & EVP, Head of Research) and Ovid Therapeutics Inc. (OVID) (Director). Across all of them we count 0 purchases worth $0 and 152 sales worth $19.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 66 sales ($9.6M). The largest single trade was a sale of 8,168 shares of Alnylam Pharmaceuticals, INC. worth $3.7M, dated 2025-11-17. The first filing on our record is dated 2021-10-07 and the latest 2026-04-09.
Alnylam Pharmaceuticals, INC. (ALNY)
CSO & EVP, Head of Research · 15 filings · 152 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-06-25 | S, sale reported on Form 4 | 161 | $37.4K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 86 | $20.1K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 138 | $32.4K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 125 | $29.4K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 74 | $17.1K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 227 | $52.2K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 198 | $45.4K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 96 | $21.9K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 26 | $5.9K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 13 | $2.9K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 9 | $2.0K | 2024-06-26 |
| 2024-06-25 | S, sale reported on Form 4 | 45 | $10.0K | 2024-06-26 |
| 2024-08-12 | S, sale reported on Form 4 | 9,662 | $2.6M | 2024-08-14 |
| 2024-08-12 | S, sale reported on Form 4 | 5,736 | $1.6M | 2024-08-14 |
| 2024-08-12 | S, sale reported on Form 4 | 3,913 | $1.1M | 2024-08-14 |
| 2024-08-12 | S, sale reported on Form 4 | 1,421 | $381.8K | 2024-08-14 |
| 2024-08-12 | S, sale reported on Form 4 | 135 | $37.1K | 2024-08-14 |
| 2024-08-12 | S, sale reported on Form 4 | 1,158 | $317.0K | 2024-08-14 |
| 2024-11-26 | S, sale reported on Form 4 | 84 | $21.2K | 2024-11-27 |
| 2024-11-26 | S, sale reported on Form 4 | 826 | $207.7K | 2024-11-27 |
| 2024-11-26 | S, sale reported on Form 4 | 318 | $79.7K | 2024-11-27 |
| 2024-11-26 | S, sale reported on Form 4 | 215 | $53.7K | 2024-11-27 |
| 2024-11-26 | S, sale reported on Form 4 | 26 | $6.4K | 2024-11-27 |
| 2024-11-27 | S, sale reported on Form 4 | 851 | $214.4K | 2024-11-27 |
| 2024-11-27 | S, sale reported on Form 4 | 360 | $91.2K | 2024-11-27 |
| 2024-11-27 | S, sale reported on Form 4 | 110 | $28.0K | 2024-11-27 |
| 2024-11-27 | S, sale reported on Form 4 | 210 | $52.6K | 2024-11-27 |
| 2025-02-14 | S, sale reported on Form 4 | 12 | $3.1K | 2025-02-18 |
| 2025-02-14 | S, sale reported on Form 4 | 21 | $5.5K | 2025-02-18 |
| 2025-02-14 | S, sale reported on Form 4 | 26 | $6.8K | 2025-02-18 |
| 2025-02-14 | S, sale reported on Form 4 | 12 | $3.2K | 2025-02-18 |
| 2025-02-14 | S, sale reported on Form 4 | 14 | $3.7K | 2025-02-18 |
| 2025-02-14 | S, sale reported on Form 4 | 33 | $8.5K | 2025-02-18 |
| 2025-02-14 | S, sale reported on Form 4 | 26 | $6.7K | 2025-02-18 |
| 2025-02-14 | S, sale reported on Form 4 | 53 | $13.6K | 2025-02-18 |
| 2025-02-14 | S, sale reported on Form 4 | 47 | $12.0K | 2025-02-18 |
| 2025-02-14 | S, sale reported on Form 4 | 110 | $28.0K | 2025-02-18 |
| 2025-02-14 | S, sale reported on Form 4 | 164 | $41.6K | 2025-02-18 |
| 2025-02-14 | S, sale reported on Form 4 | 145 | $36.6K | 2025-02-18 |
| 2025-02-18 | S, sale reported on Form 4 | 1,086 | $271.7K | 2025-02-18 |
| 2025-02-18 | S, sale reported on Form 4 | 115 | $28.9K | 2025-02-18 |
| 2025-02-18 | S, sale reported on Form 4 | 80 | $20.5K | 2025-02-18 |
| 2025-02-18 | S, sale reported on Form 4 | 83 | $21.5K | 2025-02-18 |
| 2025-02-18 | S, sale reported on Form 4 | 76 | $19.6K | 2025-02-18 |
| 2025-02-28 | S, sale reported on Form 4 | 22 | $5.3K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 48 | $11.5K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 79 | $19.1K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 187 | $45.3K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 37 | $9.0K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 75 | $18.2K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 27 | $6.4K | 2025-03-03 |
| 2025-02-28 | S, sale reported on Form 4 | 21 | $5.0K | 2025-03-03 |
| 2025-03-03 | S, sale reported on Form 4 | 219 | $53.7K | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 487 | $118.8K | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 465 | $112.9K | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 1 | $248 | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 4 | $989 | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 45 | $11.1K | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 111 | $27.2K | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 151 | $36.9K | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 224 | $54.5K | 2025-03-05 |
| 2025-03-03 | S, sale reported on Form 4 | 204 | $49.4K | 2025-03-05 |
| 2025-03-04 | S, sale reported on Form 4 | 324 | $78.3K | 2025-03-05 |
| 2025-03-04 | S, sale reported on Form 4 | 121 | $28.9K | 2025-03-05 |
| 2025-03-04 | S, sale reported on Form 4 | 71 | $17.2K | 2025-03-05 |
| 2025-03-04 | S, sale reported on Form 4 | 328 | $79.0K | 2025-03-05 |
| 2025-08-18 | S, sale reported on Form 4 | 39 | $17.6K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 241 | $109.6K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 39 | $17.5K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 90 | $40.5K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 12 | $5.5K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 103 | $46.6K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 329 | $149.0K | 2025-08-19 |
| 2025-08-18 | S, sale reported on Form 4 | 543 | $246.5K | 2025-08-19 |
| 2025-10-02 | S, sale reported on Form 4 | 555 | $251.2K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 276 | $124.7K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 449 | $202.4K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 207 | $93.1K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 150 | $67.3K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 47 | $21.1K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 96 | $42.9K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 3 | $1.4K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 273 | $123.9K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 60 | $27.3K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 203 | $92.3K | 2025-10-03 |
| 2025-10-02 | S, sale reported on Form 4 | 122 | $55.8K | 2025-10-03 |
| 2025-11-17 | S, sale reported on Form 4 | 96 | $43.2K | 2025-11-19 |
| 2025-11-17 | S, sale reported on Form 4 | 129 | $58.2K | 2025-11-19 |
| 2025-11-17 | S, sale reported on Form 4 | 368 | $167.5K | 2025-11-19 |
| 2025-11-17 | S, sale reported on Form 4 | 364 | $166.1K | 2025-11-19 |
| 2025-11-17 | S, sale reported on Form 4 | 262 | $119.8K | 2025-11-19 |
| 2025-11-17 | S, sale reported on Form 4 | 794 | $364.0K | 2025-11-19 |
| 2025-11-17 | S, sale reported on Form 4 | 622 | $286.1K | 2025-11-19 |
| 2025-11-17 | S, sale reported on Form 4 | 707 | $325.8K | 2025-11-19 |
| 2025-11-17 | S, sale reported on Form 4 | 8,168 | $3.7M | 2025-11-19 |
| 2025-11-17 | S, sale reported on Form 4 | 323 | $149.2K | 2025-11-19 |
| 2025-11-17 | S, sale reported on Form 4 | 295 | $136.6K | 2025-11-19 |
| 2026-01-12 | S, sale reported on Form 4 | 39 | $13.8K | 2026-01-14 |
| 2026-01-12 | S, sale reported on Form 4 | 42 | $14.9K | 2026-01-14 |
| 2026-01-12 | S, sale reported on Form 4 | 41 | $14.6K | 2026-01-14 |
Newest 100 of 152
Ovid Therapeutics Inc. (OVID)
Director · 8 filings · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1886431) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms